Education
About Us
Working with TipRanks
Follow Us
Sihuan Pharmaceutical Holdings Group Ltd. (HK:0460)
:0460
0460 Stock Chart & Stats
HK$1.51
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$1.51
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$0.53 - HK$1.92
Previous CloseN/A
Volume8.01M
Average Volume (3M)63.01M
Market Cap
$13.62B
Enterprise ValueHK$7.73B
Total Cash (Recent Filing)$3.60B
Total Debt (Recent Filing)$1.03B
Price to Earnings (P/E)―
Beta1.09
Next Earnings
Mar 31, 2026EPS EstimateN/A
Last Dividend Ex-Date
Sep 26, 2025Dividend Yield0.72%
Share Statistics
EPS (TTM)0.01
Shares Outstanding9,329,999,000
10 Day Avg. Volume76,396,253
30 Day Avg. Volume63,014,629
Financial Highlights & Ratios
PEG Ratio-0.09
Price to Book (P/B)1.31
Price to Sales (P/S)3.02
P/FCF Ratio99.87
Enterprise Value/Market Cap0.57
Enterprise Value/Revenue3.68
Enterprise Value/Gross Profit5.56
Enterprise Value/Ebitda-420.66
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
Sihuan Pharmaceutical Holdings Group News
0460 FAQ
What was Sihuan Pharmaceutical Holdings Group Ltd.’s price range in the past 12 months?
Sihuan Pharmaceutical Holdings Group Ltd. lowest stock price was HK$0.53 and its highest was HK$1.92 in the past 12 months.
What is Sihuan Pharmaceutical Holdings Group Ltd.’s market cap?
Sihuan Pharmaceutical Holdings Group Ltd.’s market cap is $13.62B.
When is Sihuan Pharmaceutical Holdings Group Ltd.’s upcoming earnings report date?
Sihuan Pharmaceutical Holdings Group Ltd.’s upcoming earnings report date is Mar 31, 2026 which is in 149 days.
How were Sihuan Pharmaceutical Holdings Group Ltd.’s earnings last quarter?
Sihuan Pharmaceutical Holdings Group Ltd. released its earnings results on Aug 29, 2025. The company reported HK$0.012 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.012.
Is Sihuan Pharmaceutical Holdings Group Ltd. overvalued?
According to Wall Street analysts Sihuan Pharmaceutical Holdings Group Ltd.’s price is currently Overvalued.
Does Sihuan Pharmaceutical Holdings Group Ltd. pay dividends?
Sihuan Pharmaceutical Holdings Group Ltd. pays a Annually dividend of HK$0.011 which represents an annual dividend yield of 0.72%. See more information on Sihuan Pharmaceutical Holdings Group Ltd. dividends here
What is Sihuan Pharmaceutical Holdings Group Ltd.’s EPS estimate?
Sihuan Pharmaceutical Holdings Group Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sihuan Pharmaceutical Holdings Group Ltd. have?
Sihuan Pharmaceutical Holdings Group Ltd. has 9,329,999,000 shares outstanding.
What happened to Sihuan Pharmaceutical Holdings Group Ltd.’s price movement after its last earnings report?
Sihuan Pharmaceutical Holdings Group Ltd. reported an EPS of HK$0.012 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.329%.
Which hedge fund is a major shareholder of Sihuan Pharmaceutical Holdings Group Ltd.?
Currently, no hedge funds are holding shares in HK:0460
Sihuan Pharmaceutical Holdings Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
11.11%
12-Months-Change
Fundamentals
Return on Equity
-1.87%
Trailing 12-Months
Asset Growth
-6.55%
Trailing 12-Months
Company Description
Sihuan Pharmaceutical Holdings Group Ltd.
Sihuan Pharmaceutical Holdings Group (0460) is a leading biopharmaceutical company based in China, specializing in the research, development, manufacturing, and commercialization of a wide range of pharmaceutical products. The company operates primarily in the cardiovascular, central nervous system, and anti-infection sectors, offering a diverse portfolio that includes both prescription and over-the-counter medications. Sihuan is dedicated to improving healthcare outcomes through innovative drug formulations and is involved in both traditional pharmaceutical development and biopharmaceutical solutions.
Technical Analysis
China Traditional Chinese Medicine Holdings Co
―
Consun Pharmaceutical Group Ltd.
―
―
CanSino Biologics, Inc. Class H
―
Shandong Xinhua Pharmaceutical Company Limited Class H
―
Options Prices
Currently, No data available
---